Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient
Lung transplantation is the ultimate treatment of end-stage lung disease. After transplantation, the 1-year survival rate is 80%, while the 5-year survival rates remaines at around 50% mainly due to bronchiolitis obliterans syndrome (BOS). BOS is regarded as a fibrosing process in the small airways...
Main Authors: | Sijia YANG, Abudumailamu ABUDUWUFUER, Wang LV, Feichao BAO, Jian HU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-06-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.03 |
Similar Items
-
The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans
by: Chong Zhang, et al.
Published: (2017-12-01) -
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
by: Dalila Cavallaro, et al.
Published: (2022-12-01) -
The role of HIF-1α-VEGF pathway in bronchiolitis obliterans after lung transplantation
by: Haichao Xu, et al.
Published: (2019-01-01) -
Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation
by: Anna Winkler, et al.
Published: (2018-09-01) -
Postinfectious Bronchiolitis Obliterans
by: Aslı İmran Yılmaz, et al.
Published: (2021-12-01)